tradingkey.logo
tradingkey.logo

Hims & Hers Health Inc

HIMS
View Detailed Chart
21.340USD
0.0000.00%
Close 03/24, 16:00ETQuotes delayed by 15 min
536.83MMarket Cap
37.40P/E TTM

Hims & Hers Health Inc

21.340
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

-14.57%

1 Month

+38.03%

6 Months

-59.92%

Year to Date

-34.28%

1 Year

-42.96%

View Detailed Chart

Key Insights

Hims & Hers Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 25 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 25.38.In the medium term, the stock price is expected to trend down.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Hims & Hers Health Inc's Score

Industry at a Glance

Industry Ranking
25 / 75
Overall Ranking
143 / 4547
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive+

Hims & Hers Health Inc Highlights

StrengthsRisks
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 169.22% year-on-year.
Fairly Valued
The company’s latest PE is 37.40, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 210.10M shares, decreasing 3.76% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 20.88M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.72.

Analyst Rating

Based on 16 analysts
Hold
Current Rating
25.380
Target Price
+15.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Hims & Hers Health Inc News

Hims & Hers Soars 64% in Three Days as Novo Nordisk Deal Opens Door to GLP-1 Market

TradingKey - Shares of Hims & Hers Health (HIMS.US) surged nearly 64% cumulatively over the first three trading days of this week, with an intraday rally of over 10% on Wednesday.

TradingKeyThu, Mar 12
TradingKey - Shares of Hims & Hers Health (HIMS.US) surged nearly 64% cumulatively over the first three trading days of this week, with an intraday rally of over 10% on Wednesday.

Investing in Health Stock: Will GLP-1 Pill Copycat Restrictions Derail Hims & Hers? Is HIMS Still a Good Choice in 2026?

Hims & Hers' subscription-based business model, coupled with tailored treatment regimens, allows users to maintain lasting engagement, a critical aspect of the company’s growth narrative and a reason why some see Hims & Hers stock as a play on long-term digital health as opposed to a traditional pha

TradingKeyTue, Feb 10
Hims & Hers' subscription-based business model, coupled with tailored treatment regimens, allows users to maintain lasting engagement, a critical aspect of the company’s growth narrative and a reason why some see Hims & Hers stock as a play on long-term digital health as opposed to a traditional pha

Hims & Hers Health Inc (HIMS): The Opportunity is still Strong and Potent

TradingKey - Despite the whole controversy with NVO, we believe HIMS is able to achieve 6 million subscribers and $6 billion of revenue by 2030, due to the large opportunity of growth for the telehealth industry, early investments in logistics capabilities and ability to upsell their patients.

TradingKeyMon, Sep 1
TradingKey - Despite the whole controversy with NVO, we believe HIMS is able to achieve 6 million subscribers and $6 billion of revenue by 2030, due to the large opportunity of growth for the telehealth industry, early investments in logistics capabilities and ability to upsell their patients.

Hims & Hers: A Game-Changer in Telehealth or Just Another Fad?

Explore the exciting world of Hims & Hers (NYSE: HIMS) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!

OtherFri, Aug 8
Explore the exciting world of Hims & Hers (NYSE: HIMS) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!

HIMS: When Overvaluation Isn’t What It Seems

TradingKey - The stock market is sending mixed messages about Hims & Hers Health (HIMS). On the plus side, the shares are trading higher by approximately 16% for the day, continuing a red-hot YTD run; on the other, the stock looks overvalued on paper with GAAP P/E and EV/EBITDA multiples several tim

TradingKeyFri, May 23
TradingKey - The stock market is sending mixed messages about Hims & Hers Health (HIMS). On the plus side, the shares are trading higher by approximately 16% for the day, continuing a red-hot YTD run; on the other, the stock looks overvalued on paper with GAAP P/E and EV/EBITDA multiples several tim

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Hims & Hers Health Inc Info

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Ticker SymbolHIMS
CompanyHims & Hers Health Inc
CEODudum (Andrew)
Websitehttps://www.forhims.com/
KeyAI